Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' JAGER U' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 78 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Fonatsch, C; Nowotny, H; Pittermann-Hocker, E; Streubel, B; Jager, U; Valent, P; Buchner, T; Lechner, K
      Amplification of ribosomal RNA genes in acute myeloid leukemia

      GENES CHROMOSOMES & CANCER
    2. Exner, M; Thalhammer-Scherrer, R; Kudlacek, S; Simonitsch, I; Jager, U; Schwarzinger, I
      Suspect cell convolutes in the bone marrow of a patient with renal cell carcinoma unmasked as atypical convolutes of hairy cells

      LEUKEMIA & LYMPHOMA
    3. Keil, F; Prinz, F; Kalhs, P; Lechner, K; Moser, K; Schwarzinger, I; Jager, U; Fonatsch, C; Worel, N; Mannhalter, C; Rabitsch, W; Loidolt, H; Schulenburg, A; Mitterbauer, M; Hocker, P; Greinix, HT
      Treatment of leukemic relapse after allogeneic stem cell transplantation with cytotoreductive chemotherapy and/or immunotherapy or second transplants

      LEUKEMIA
    4. Selenko, N; Majdic, O; Draxler, S; Berer, A; Jager, U; Knapp, W; Stockl, J
      CD20 antibody (C2B8)-induced apoptosis of lymphoma cells promotes phagocytosis by dendritic cells and cross-priming of CD8(+) cytotoxic T cells

      LEUKEMIA
    5. Falkenbach, A; Jager, U
      Is chronic lymphocytic leukemia a contraindication for radon and thermotherapy? - A case report

      WIENER KLINISCHE WOCHENSCHRIFT
    6. Pirc-Danoewinata, H; Dauwerse, HG; Konig, M; Chudoba, I; Mitterbauer, M; Jager, U; Breuning, MH; Haas, OA
      CBFB/MYHII fusion in a patient with AML-M4Eo and cytogenetically normal chromosomes 16

      GENES CHROMOSOMES & CANCER
    7. Streubel, B; Valent, P; Jager, U; Edelhauser, M; Wandt, H; Wagner, T; Buchner, T; Lechner, K; Fonatsch, C
      Amplification of the MLL gene on double minutes, a homogeneously staining region, and ring chromosomes in five patients with acute myeloid leukemia or myelodysplastic syndrome

      GENES CHROMOSOMES & CANCER
    8. Mavria, G; Jager, U; Porter, CD
      Generation of a high titre retroviral vector for endothelial cell-specificgene expression in vivo

      GENE THERAPY
    9. Greinix, HT; Loidolt, H; Rabitsch, W; Schulenburg, A; Keil, F; Mitterbauer, M; Laczika, K; Lechner, K; Dieckmann, K; Fischer, G; Jager, U; Rosenmayr, A; Knobl, P; Schwarzinger, I; Hocker, P; Mannhalter, C; Hinterberger, W; Haas, OA; Fonatsch, C; Kalhs, P
      Excellent disease eradication by myeloablative therapy and stem-cell transplantation in patients with acute myelogenous leukemia

      ANNALS OF HEMATOLOGY
    10. Thalhammer-Scherrer, R; Geissler, K; Schwarzinger, I; Chott, A; Gisslinger, H; Knobl, P; Lechner, K; Jager, U
      Fludarabine therapy in Waldenstrom's macroglobulinemia

      ANNALS OF HEMATOLOGY
    11. Konigsberg, R; Ackermann, J; Kaufmann, H; Zojer, N; Urbauer, E; Kromer, E; Jager, U; Gisslinger, H; Schreiber, S; Heinz, R; Ludwig, H; Huber, H; Drach, J
      Deletions of chromosome 13q in monoclonal gammopathy of undetermined significance

      LEUKEMIA
    12. Filipits, M; Stranzl, T; Pohl, G; Heinzl, H; Jager, U; Geissler, K; Fonatsch, C; Haas, OA; Lechner, K; Pirker, R
      Drug resistance factors in acute myeloid leukemia: a comparative analysis

      LEUKEMIA
    13. Konigsberg, R; Zojer, N; Ackermann, J; Kromer, E; Kittler, H; Fritz, E; Kaufmann, H; Nosslinger, T; Riedl, L; Gisslinger, H; Jager, U; Simonitsch, I; Heinz, R; Ludwig, H; Huber, H; Drach, J
      Predictive role of interphase cytogenetics for survival of patients with multiple myeloma

      JOURNAL OF CLINICAL ONCOLOGY
    14. Exner, M; Thalhammer, R; Kapiotis, S; Mitterbauer, G; Knobl, P; Haas, OA; Jager, U; Schwarzinger, I
      The "typical" immunophenotype of acute promyelocytic leukemia (APL-M3): Does it prove true for the M3-variant?

      CYTOMETRY
    15. Fureder, W; Streubel, B; Jordan, JH; Walchshofer, S; Wimazal, F; Jager, U; Geissler, K; Schwartz, LB; Chott, A; Lechner, K; Valent, P; Fonatsch, C
      Reciprocal translocation (3;5)(q26;q22) and possible BCHE gene involvementin an unusual myelogenous disorder with bath myeloproliferative and dysplastic features

      CANCER GENETICS AND CYTOGENETICS
    16. Geissler, K; Gisslinger, H; Knobl, P; Sperr, W; Valent, P; Dieckmann, K; Chott, A; Potter, R; Lechner, K; Jager, U
      Efficacy of standard treatment in patients with Hodgkin's disease - A single center experience

      WIENER KLINISCHE WOCHENSCHRIFT
    17. Wieser, R; Volz, A; Schnittger, S; Jager, U; Gruner, H; Meran, JG; Wimmer, K; Ziegler, A; Fonatsch, C
      Mapping of leukaemia-associated breakpoints in chromosome band 3q21 using a newly established PAC contig

      BRITISH JOURNAL OF HAEMATOLOGY
    18. Mitterbauer, G; Zimmer, C; Pirc-Danoewinata, H; Haas, OA; Hojas, S; Schwarzinger, I; Greinix, H; Jager, U; Lechner, K; Mannhalter, C
      Monitoring of minimal residual disease in patients with MLL-AF6-positive acute myeloid leukaemia by reverse transcriptase polymerase chain reaction

      BRITISH JOURNAL OF HAEMATOLOGY
    19. Jager, U; Bocskor, S; Le, T; Mitterbauer, G; Bolz, I; Chott, A; Kneba, M; Mannhalter, C; Nadel, B
      Follicular lymphomas' BCL-2/IgH junctions contain templated nucleotide insertions: novel insights into the mechanism of t(14;18) translocation

      BLOOD
    20. Wieser, R; Volz, A; Vinatzer, U; Gardiner, K; Jager, U; Mitterbauer, M; Ziegler, A; Fonatsch, C
      Transcription factor GATA-2 gene is located near 3q21 breakpoints in myeloid leukemia

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    21. Fiegl, M; Mitterbauer, G; Weltermann, A; Pirc-Danoewinata, H; Jager, U
      Chronic myelogenous leukemia in chronic phase for 16 years: Ongoing hematological remission and late minor cytogenetic response under minimal interferon maintenance therapy

      LEUKEMIA & LYMPHOMA
    22. Jager, U; Takeuchi, Y; Porter, CD
      Induction of complement attack on human cells by Gal(alpha 1,3)Gal xenoantigen expression as a gene therapy approach to cancer

      GENE THERAPY
    23. Meidlinger, P; Knobl, P; Jager, U; Gisslinger, H; Pabinger, I; Weltermann, A; Lechner, K; Geissler, K
      Granulocyte colony-stimulating factor-supported combined immunosuppressivetherapy (antilymphocyte globulin, cyclosporine, and methylprednisolone) inpatients with aplastic anemia: tolerability, efficacy, and changes in the progenitor cell compartment

      ANNALS OF HEMATOLOGY
    24. Lechner, K; Geissler, K; Jager, U; Greinix, H; Kalhs, P
      Treatment of acute leukemia

      ANNALS OF ONCOLOGY
    25. Fureder, W; Weltermann, A; Chott, A; Gisslinger, H; Valent, P; Jager, U; Geissler, K; Lechner, K
      Treatment of hairy cell leukemia with cladribine (2-chlorodeoxyadenosine)

      WIENER KLINISCHE WOCHENSCHRIFT
    26. Jager, U; Zhao, Y; Porter, CD
      Endothelial cell-specific transcriptional targeting from a hybrid long terminal repeat retrovirus vector containing human prepro-endothelin-1 promoter sequences

      JOURNAL OF VIROLOGY
    27. Jager, U; Nguyen-Duong, H
      Relaxant effect of trans-resveratrol on isolated porcine coronary arteries

      ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH
    28. WELTERMANN A; PABINGER I; GEISSLER K; JAGER U; GISSLINGER H; KNOBL P; EICHINGER S; KYRLE PA; VALENT P; SPEISER W; SCHWARZINGER I; MANNHALTER C; LECHNER K
      HYPOFIBRINOGENEMIA IN NON-M3 ACUTE MYELOID-LEUKEMIA - INCIDENCE, CLINICAL AND LABORATORY CHARACTERISTICS AND PROGNOSIS

      Leukemia
    29. Gaiger, A; Schmid, D; Heinze, G; Linnerth, B; Greinix, H; Kalhs, P; Tisljar, K; Priglinger, S; Laczika, K; Mitterbauer, M; Novak, M; Mitterbauer, G; Mannhalter, C; Haas, OA; Lechner, K; Jager, U
      Detection of the WT1 transcript by RT-PCR in complete remission has no prognostic relevance in de novo acute myeloid leukemia

      LEUKEMIA
    30. SCHETT G; CASATI B; WILLINGER B; WEINLANDRE G; BINDER T; GRABENWOGER F; SPERR W; GEISSLER K; JAGER U
      ENDOCARDITIS AND AORTIC EMBOLIZATION CAUSED BY ASPERGILLUS-TERREUS INA PATIENT WITH ACUTE LYMPHOBLASTIC-LEUKEMIA IN REMISSION - DIAGNOSIS BY PERIPHERAL-BLOOD CULTURE

      Journal of clinical microbiology (Print)
    31. LECHNER K; JAGER U; GEISSLER K; GREINIX H; KALHS P
      ADVANCES IN THE TREATMENT OF CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL)

      Wiener Klinische Wochenschrift
    32. MORRISON AM; JAGER U; CHOTT A; SCHEBESTA M; HAAS OA; BUSSLINGER M
      DEREGULATED PAX-5 TRANSCRIPTION FROM A TRANSLOCATED IGH PROMOTER IN MARGINAL ZONE LYMPHOMA

      Blood
    33. FILIPITS M; POHL G; STRANZL T; SUCHOMEL RW; SCHEPER RJ; JAGER U; GEISSLER K; LECHNER K; PIRKER R
      EXPRESSION OF THE LUNG RESISTANCE PROTEIN PREDICTS POOR OUTCOME IN DE-NOVO ACUTE MYELOID-LEUKEMIA

      Blood
    34. JAGER U; TAKEUCHI Y; PORTER CD
      SENSITIZATION OF HUMAN-CELLS TO LYSIS BY HUMAN-COMPLEMENT AS AN APPROACH FOR CANCER GENE-THERAPY

      Cancer gene therapy
    35. SCHMID D; HEINZE G; LINNERTH B; TISLJAR K; KUSEC R; GEISSLER K; SILLABER C; LACZIKA K; MITTERBAUER M; ZOCHBAUER S; MANNHALTER C; HAAS OA; LECHNER K; JAGER U; GAIGER A
      PROGNOSTIC-SIGNIFICANCE OF WT1 GENE-EXPRESSION AT DIAGNOSIS IN ADULT DE-NOVO ACUTE MYELOID-LEUKEMIA

      Leukemia
    36. MITTERBAUER M; HILGENFELD E; WILFING A; JAGER U; KNAUF WU
      IS THERE A PLACE FOR 2-CDA IN THE TREATMENT OF B-CLL

      Leukemia
    37. HAAS M; JAGER U; MAYER G
      INTERFERON ALFA-2C AND PROTEINURIA IN A PATIENT WITH FOCAL AND SEGMENTAL GLOMERULOSCLEROSIS

      Lancet
    38. TAKEUCHI Y; LIONG SH; BIENIASZ PD; JAGER U; PORTER CD; FRIEDMANN T; MCCLURE MO; WEISS RA
      SENSITIZATION OF RHABDOVIRUSES, LENTIVIRUSES, AND SPUMAVIRUSES TO HUMAN SERUM BY GALACTOSYL(ALPHA-1-3)GALACTOSYLATION

      Journal of virology
    39. SPERR WR; PIRIBAUER M; AGIS H; MITTERBAUER M; GEISSLER K; HAAS O; FONATSCH C; JAGER U; SCHWARZINGER I; THALHAMMER F; VALENT P; LECHNER K
      INTERMITTENT INTERMEDIATE-DOSE ARA-C AS CONSOLIDATION THERAPY FOR AMLIN THE ELDERLY

      Blood
    40. PIRKER R; POHL G; STRANZL T; SUCHOMEL RW; SCHEPER RJ; JAGER U; GEISSLER K; LECHNER K; FILIPITS M
      EXPRESSION OF THE LUNG RESISTANCE PROTEIN (LRP) PREDICTS POOR OUTCOMEIN DE-NOVO ACUTE MYELOID-LEUKEMIA

      Blood
    41. HUHMANN IM; WATZKE HH; GEISSLER K; GISSLINGER H; JAGER U; KNOBL P; PABINGER I; KORNINGER L; MANNHALTER C; MITTERBAUER G; SCHWARZINGER I; KALHS P; HAAS OA; LECHNER K
      FLAG (FLUDARABINE, CYTOSINE-ARABINOSIDE, G-CSF) FOR REFRACTORY AND RELAPSED ACUTE MYELOID-LEUKEMIA

      Annals of hematology
    42. THALHAMMER F; GEISSLER K; JAGER U; KYRLE PA; PABINGER I; MITTERBAUER M; GISSLINGER H; KNOBL P; LACZIKA K; SCHNEIDER B; HAAS OA; LECHNER K
      DURATION OF 2ND COMPLETE REMISSION IN PATIENTS WITH ACUTE MYELOID-LEUKEMIA TREATED WITH CHEMOTHERAPY - A RETROSPECTIVE SINGLE-CENTER STUDY

      Annals of hematology
    43. GREINIX HT; KEIL F; BRUGGER SA; REITER E; LINKESCH W; LECHNER K; SCHNEIDER B; DIECKMANN KU; FISCHER G; SCHWARZINGER I; HAAS O; HINTERBERGER W; MANNHALTER C; GEISSLER K; HOCKER P; JAGER U; KALHS P
      LONG-TERM LEUKEMIA-FREE SURVIVAL AFTER ALLOGENEIC MARROW TRANSPLANTATION IN PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA

      Annals of hematology
    44. HAAS M; MANNHALTER C; ULLRICH R; SCHWARZINGER I; ZUCKERMANN A; DERFLER K; JAGER U
      A MULTILOCULAR B-CELL NEOPLASIA PRESENTING AS MULTIPLE-MYELOMA AND POLYMORPHIC LYMPHOMA OF RECIPIENT ORIGIN 2 MONTHS AFTER KIDNEY-TRANSPLANTATION IN A HEART-TRANSPLANT RECIPIENT

      Nephrology, dialysis, transplantation
    45. FAGETH R; ALLEN WG; JAGER U
      FUZZY-LOGIC CLASSIFICATION IN IMAGE-PROCESSING

      Fuzzy sets and systems
    46. JAGER U; LACZIKA K; SCHOLTEN C; MITTERBAUER M; NOVAK M; LECHNER K
      CLINICAL USE OF THE POLYMERASE CHAIN-REAC TION FOR DIAGNOSIS AND MONITORING OF MALIGNANT DISEASES

      Wiener Klinische Wochenschrift
    47. LORKOVIC H; JAGER U
      CHLORPROMAZINE AND DILTIAZEM EFFECTS IN MUSCLE - BLOCKAGE OF ACETYLCHOLINE-EVOKED CONTRACTURES, MEMBRANE CURRENTS AND TRACER CALCIUM-UPTAKE

      Pharmacology
    48. COLLINS M; TAKEUCHI Y; PORTER C; JAGER U; MARTIN P; EVERARD M; PALMER K; BRIDGEWATER J; BOX G; WEISS R
      RETROVIRUSES FOR GENE-THERAPY

      Immunology
    49. FODINGER M; BUCHMAYER H; SCHWARZINGER I; SIMONITSCH I; WINKLER K; JAGER U; KNOBLER R; MANNHALTER C
      MULTIPLEX PCR FOR RAPID DETECTION OF T-CELL RECEPTOR-GAMMA CHAIN GENEREARRANGEMENTS IN PATIENTS WITH LYMPHOPROLIFERATIVE DISEASES

      British Journal of Haematology
    50. LORKOVIC H; JAGER U; RADOCAJ A
      COMPARISON OF THE EFFECTS OF CA2-PLATE CURRENTS IN MOUSE INTEROSSEUS MUSCLES( AND THOSE OF MG2+ AND LA3+ ON END)

      Comparative biochemistry and physiology. Part A, Physiology
    51. TRIBL B; KNOBL P; DERFLER K; KAPIOTIS S; ASPOCK G; JAGER U; HORL W; LECHNER K
      RAPID ELIMINATION OF A HIGH-TITER SPONTANEOUS FACTOR-V ANTIBODY BY EXTRACORPOREAL ANTIBODY-BASED IMMUNOADSORPTION AND IMMUNOSUPPRESSION

      Annals of hematology
    52. KNOBL P; DERFLER K; KORNINGER L; KAPIOTIS S; JAGER U; MAIERDOBERSBERGER T; HORL W; LECHNER K; PABINGER I
      ELIMINATION OF ACQUIRED FACTOR-VIII ANTIBODIES BY EXTRACORPOREAL ANTIBODY-BASED IMMUNOADSORPTION (IG-THERASORB(R))

      Thrombosis and haemostasis
    53. KNOBL P; DERFLER K; KORNINGER L; KAPIOTIS S; JAGER U; MAIENDOBERSBERGER T; TRIBL B; SPEISER W; DRUML W; PABINGER I; LECHNER K
      ELIMINATION OF ACQUIRED INHIBITORS TO FACTOR-VIII AND FACTOR-V WITH IMMUNOSPECIFIC IMMUNOGLOBULIN APHERESIS

      Thrombosis and haemostasis
    54. DRACH J; SCHUSTER J; NOWOTNY H; ANGERLER J; ROSENTHAL F; FIEGL M; ROTHERMUNDT C; GSUR A; JAGER U; HEINZ R; LECHNER K; LUDWIG H; HUBER H
      MULTIPLE-MYELOMA - HIGH-INCIDENCE OF CHROMOSOMAL ANEUPLOIDY AS DETECTED BY INTERPHASE FLUORESCENCE IN-SITU HYBRIDIZATION

      Cancer research
    55. MITTERBAUER G; FODINGER M; SCHERRER R; KNOBL P; JAGER U; LACZIKA K; SCHWARZINGER I; GAIGER A; GEISSLER K; GREINIX H; KALHS P; LINKESCH W; LECHNER K; MANNHALTER C
      PCR-MONITORING OF MINIMAL RESIDUAL LEUKEMIA AFTER CONVENTIONAL CHEMOTHERAPY AND BONE-MARROW TRANSPLANTATION IN BCR-ABL-POSITIVE ACUTE LYMPHOBLASTIC-LEUKEMIA

      British Journal of Haematology
    56. REITER E; OHLER L; MAJDIC O; JAGER U; LECHNER K; GEISSLER K
      DOWN-REGULATION OF UROKINASE RECEPTOR (CD87) EXPRESSION BY IL-4 ON U937 MONONUCLEAR PHAGOCYTES

      Blood
    57. REITER E; OHLER L; MAJDIC O; JAGER U; LECHNER K; GEISSLER K
      DOWN-REGULATION OF UROKINASE RECEPTOR (CD87) EXPRESSION BY IL-4 ON U937 MONONUCLEAR PHAGOCYTES

      Blood
    58. GEISSLER K; OHLER L; REITER E; KABRNA E; ROGY M; FODINGER M; MANNHALTER C; JAGER U; LECHNER K
      INHIBITORY EFFECT OF INTERLEUKIN-10 ON THE AUTONOMOUS IN-VITRO GROWTHOF CHRONIC MYELOMONOCYTIC LEUKEMIA-CELLS

      Blood
    59. DRACH J; ANGERLER J; SCHUSTER J; ROTHERMUNDT C; THALHAMMER R; HAAS OA; JAGER U; FIEGL M; GEISSLER K; LUDWIG H; HUBER H
      INTERPHASE FLUORESCENCE IN-SITU HYBRIDIZATION IDENTIFIES CHROMOSOMAL-ABNORMALITIES IN PLASMA-CELLS FROM PATIENTS WITH MONOCLONAL GAMMOPATHYOF UNDETERMINED SIGNIFICANCE

      Blood
    60. LORKOVIC H; BALEZINA OP; JAGER U
      ACETYLCHOLINE-EVOKED CURRENTS IN JUVENILE MOUSE MUSCLES

      Comparative biochemistry and physiology. Part C, Pharmacology toxicology & endocrinology
    61. GOTSCH U; JAGER U; DOMINIS M; VESTWEBER D
      EXPRESSION OF P-SELECTIN ON ENDOTHELIAL-CELLS IS UP-REGULATED BY LPS AND TNF-ALPHA IN-VIVO

      Cell adhesion and communication
    62. SCHERRER R; BETTELHEIM P; GEISSLER K; JAGER U; KNOBL P; KYRLE PA; LACZIKA K; MITTERBAUER G; NEUMANN E; SCHNEIDER B; SCHWARZINGER I; LECHNER K
      HIGH EFFICACY OF THE GERMAN MULTICENTER ALL (GMALL) PROTOCOL FOR TREATMENT OF ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) - A SINGLE-INSTITUTION STUDY

      Annals of hematology
    63. THALHAMMER F; GISSLINGER H; CHOTT A; HAAS O; ETELEHAINZ A; HELBICH T; KUSEC R; LINKESCH W; SIMONITSCH I; STROBL H; LECHNER K; JAGER U
      GRANULOCYTIC SARCOMA OF THE PROSTATE AS THE 1ST MANIFESTATION OF A LATE RELAPSE OF ACUTE MYELOGENOUS LEUKEMIA

      Annals of hematology
    64. PIRCDANOEWINATA H; CHOTT A; ONDERKA E; DRACH J; SCHLOGL E; JAGER U; THALHAMMER F; NOWOTNY H; ARYEE D; STEGER GG; LOCKER G; MICHL I; DJAVANMARD M; SIMONITSCH I; RADASZKIEWICZ T; HANAK H; SCHNEIDER B; HEINZ R; MAROSI C
      KARYOTYPE AND PROGNOSIS IN NON-HODGKIN-LYMPHOMA

      Leukemia
    65. NOLTE D; SCHMID P; JAGER U; BOTZLAR A; ROESKEN F; HECHT R; UHL E; MESSMER K; VESTWEBER D
      LEUKOCYTE ROLLING IN VENULES OF STRIATED-MUSCLE AND SKIN IS MEDIATED BY P-SELECTIN, NOT BY L-SELECTIN

      American journal of physiology. Heart and circulatory physiology
    66. BOCHER WO; LOHR HF; STEEGMULLER KW; STORKEL S; JAGER U; ZUMBUSCHENFELDE KHM; GERKEN G
      DETECTION OF HEPATITIS-C VIRUS-REPLICATION IN OVARIAN METASTASES OF APATIENT WITH HEPATOCELLULAR-CARCINOMA

      Journal of hepatology
    67. JAGER U; DELLEKARTH G; KNAPP S; TUENI C
      TREATMENT OF HIGH-GRADE NON-HODGKINS-LYMP HOMAS

      Wiener Klinische Wochenschrift
    68. HAHNE M; LENTER M; JAGER U; VESTWEBER D
      A NOVEL SOLUBLE FORM OF MOUSE VCAM-1 IS GENERATED FROM A GLYCOLIPID-ANCHORED SPLICING VARIANT

      European Journal of Immunology
    69. REITER E; OHLER L; AGIS H; VALENT P; JAGER U; LECHNER K; GEISSLER K
      DIFFERENTIAL-EFFECTS OF IL-4 AND IL-10 ON THE EXPRESSION OF THE C3BI RECEPTOR ON HUMAN MONOCYTES MACROPHAGES

      Blood
    70. DRACH J; ANGERLER J; SCHUSTER J; NOWOTNY H; SCHERRER R; JAGER U; HEINZ R; GEISSLER K; LECHNER K; LUDWIG H; HUBER H
      INTERPHASE CYTOGENETIC STUDIES IN MULTIPLE-MYELOMA (MM) AND MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS)

      Blood
    71. LORBER C; WILLFORT A; OHLER L; JAGER U; SCHWARZINGER I; LECHNER K; GEISSLER K
      GRANULOCYTE-COLONY-STIMULATING FACTOR (RH G-CSF) AS AN ADJUNCT TO INTERFERON-ALPHA THERAPY OF NEUTROPENIC PATIENTS WITH HAIRY-CELL LEUKEMIA

      Annals of hematology
    72. SCHERRER R; GEISSLER K; KYRLE PA; GISSLINGER H; JAGER U; BETTELHEIM P; LACZIKA K; LOCKER G; SCHOLTEN C; SILLABER C; SCHWARZINGER I; THALHAMMER F; LECHNER K
      GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF) AS AN ADJUNCT TO INDUCTION CHEMOTHERAPY OF ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL)

      Annals of hematology
    73. WILLFORT A; LORBER C; KAPIOTIS S; SERTL S; HAINZ R; KIRCHWEGER P; JAGER U; KYRLE PA; LECHNER K; GEISSLER K
      TREATMENT OF DRUG-INDUCED AGRANULOCYTOSIS WITH RECOMBINANT GRANULOCYTE-COLONY-STIMULATING FACTOR (RH G-CSF)

      Annals of hematology
    74. GAIGER A; LION T; KALHS P; MITTERBAUER G; HENN T; HAAS O; FODINGER M; KIER P; FORSTINGER C; QUEHENBERGER P; HINTERBERGER W; JAGER U; LINKESCH W; MANNHALTER C; LECHNER K
      FREQUENT DETECTION OF BCR-ABL SPECIFIC MESSENGER-RNA IN PATIENTS WITHCHRONIC MYELOID-LEUKEMIA (CML) FOLLOWING ALLOGENEIC AND SYNGENEIC BONE-MARROW TRANSPLANTATION (BMT)

      Leukemia
    75. KNOBL P; KAPIOTIS S; LACZIKA K; JAGER U; KYRLE A; SPEISER W; LECHNER K
      ATTENUATION OF THE HEMOSTATIC DISORDER IN ACUTE PROMYELOCYTIC LEUKEMIA BY TREATMENT WITH ALL-TRANS-RETINOIC ACID

      Thrombosis and haemostasis
    76. HAHNE M; LENTER M; JAGER U; ISENMANN S; VESTWEBER D
      VCAM-1 IS NOT INVOLVED IN LPAM-1 (ALPHA(4)BETA(P) ALPHA(4)BETA(7)) MEDIATED BINDING OF LYMPHOMA-CELLS TO HIGH ENDOTHELIAL VENULES OF MUCOSA-ASSOCIATED LYMPH-NODES/

      European journal of cell biology
    77. OHLER L; SCHOLTEN C; REITER E; TIEFENGRABER E; JAGER U; STROBL H; LECHNER K; HOCKER P; GEISSLER K
      MOBILIZATION OF CIRCULATING HEMATOPOIETIC STEM-CELLS WITH GRANULOCYTE-COLONY-STIMULATING FACTOR AFTER CHEMOTHERAPY IN PATIENTS WITH MULTIPLE-MYELOMA

      Wiener Klinische Wochenschrift
    78. HAHNE M; JAGER U; ISENMANN S; HALLMANN R; VESTWEBER D
      5 TUMOR NECROSIS FACTOR-INDUCIBLE CELL-ADHESION MECHANISMS ON THE SURFACE OF MOUSE ENDOTHELIOMA CELLS MEDIATE THE BINDING OF LEUKOCYTES

      The Journal of cell biology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 30/10/20 alle ore 06:14:42